Roche Holding AG
ROPharmaceuticals
CHF 409.40+1.09%As of Oct 29vs prior close
- Market cap
- $52.7B
- P/E (TTM)
- 26.7×
- P/E (FY1)
- 20.0×
- From 52W high
- 0.00%
- EPS (LTM)
- CHF 15.33
- Revenue (LTM)
- CHF 63B
- Net margin
- 19.60%
- Dividend yield
- 2.64%
Nomior Score
71
Steady ProfileTop 8% of the scored universe
Growth42
Quality68
Value55
Momentum87
Resilience63
Growth
−1.26%revenue a year over 3 fiscal years
YE22 CHF 65.8BLTM CHF 63B
Connections
Revenue to profitYE25
20% of revenue became net profit, up 7 pts on a year.